William W L Wong
Overview
Explore the profile of William W L Wong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
559
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Anyiwe K, Erman A, Hassan M, Feld J, Pullenayegum E, Wong W, et al.
Lancet Infect Dis
. 2024 Jan;
24(6):e366-e385.
PMID: 38184004
Social determinants of health are important in designing effective interventions for hepatitis B virus (HBV) infection. This systematic review characterises equity-oriented, social determinants of health-focused HBV interventions, and describes their...
12.
Lewis D, Wong W, Lipscomb J, Horton S
Pharmacoeconomics
. 2023 Dec;
42(4):393-407.
PMID: 38150120
Background: Determining whether multi-cancer early detection (MCED) tests are cost effective is important in deciding whether they should be included in the clinical path of cancer care, especially for cancers...
13.
Zeitouny S, Cheung D, Bremner K, Pataky R, Pequeno P, Matelski J, et al.
PLoS One
. 2023 Sep;
18(9):e0290646.
PMID: 37682823
Introduction: The aim of our study was to assess the initial impact of COVID-19 on total publicly-funded direct healthcare costs and health services use in two Canadian provinces, Ontario and...
14.
Wong W, Haines A, Wong J, Hamadeh A, Krahn M
Sci Rep
. 2023 Aug;
13(1):13484.
PMID: 37596309
Managing chronic hepatitis C is challenging, as the majority of those infected are asymptomatic. Therefore, to ensure treatments are administered before the onset of severe complications, screening is important. In...
15.
Erman A, Everett K, Wong W, Forouzannia F, Greenaway C, Janjua N, et al.
Hepatol Commun
. 2023 Aug;
7(9).
PMID: 37556245
Background: HCV elimination requires a thorough understanding of the care cascade. A direct-acting antiviral (DAA)-era description of the care cascade has not been undertaken in Ontario, Canada's most populous jurisdiction....
16.
Chu C, Gomes T, Antoniou T, Wong W, Janjua N, Guertin J, et al.
PLoS One
. 2023 Aug;
18(8):e0284914.
PMID: 37552677
Background: Hepatitis C virus (HCV) has high global prevalence and can lead to liver complications and death. Access to direct-acting antivirals (DAAs) in Canada increased following several policy changes, however...
17.
Chayab L, Konstantelos N, Leighl N, Tadrous M, Wong W
Pharmacoeconomics
. 2023 Jun;
41(8):945-980.
PMID: 37268866
Background: The anaplastic lymphoma kinase (ALK) inhibitor treatment landscape is rapidly evolving, providing patients with ALK-positive (+) non-small cell lung cancer (NSCLC) with multiple therapy options, multiple lines of treatments,...
18.
Wong W, Lee L, Walker S, Lee C, Patel T, Hillier L, et al.
BMJ Open
. 2023 Apr;
13(4):e064882.
PMID: 37076160
Objectives: To examine the cost-effectiveness of Multi-specialty INterprofessional Team (MINT) Memory Clinic care in comparison to the provision of usual care. Design: Using a Markov-based state transition model, we performed...
19.
Mendlowitz A, Bremner K, Krahn M, Walker J, Wong W, Sander B, et al.
CMAJ
. 2023 Apr;
195(14):E499-E512.
PMID: 37040993
Background: As First Nations Peoples are a priority focus of Canada's commitment to eliminating hepatitis C virus (HCV) as a public health threat, understanding individuals' progression from diagnosis to cure...
20.
Kim J, Alsabbagh W, Wong W
Pharmacoeconomics
. 2023 Jan;
41(4):413-425.
PMID: 36708500
Background And Objective: The World Health Organization recommends a universal hepatitis B vaccination within the first 24 h of birth. However, hepatitis B vaccines are given during adolescence in many...